{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:20:00Z","timestamp":1791382800652,"version":"4.3.3"},"reference-count":45,"publisher":"Cambridge University Press (CUP)","issue":"11","license":[{"start":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T00:00:00Z","timestamp":1537401600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infect. Control Hosp. Epidemiol."],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Tuberculosis (TB) remains an important problem among end-stage renal disease (ESRD) patients. We reviewed the epidemiology of TB and ESRD, investigations of TB exposures in US dialysis facilities, and published guidelines to inform screening and treatment practices among US ESRD patients. Compared to TB in the general population, ESRD patients have 6\u201325-fold higher TB incidence rates, and mortality during treatment is 2\u20133-fold higher. Most TB cases among ESRD patients (~90%) occur among non\u2013US-born persons, and an analysis of genotyping data suggests that 80% of all cases result from latent TB infection (LTBI) reactivation. Published TB contact investigations in dialysis facilities have reported cases among ESRD patients and healthcare workers. However, transmission of TB is rare: there were no reports of secondary cases of TB because of exposure to an index-case patient and there were few TB infections, which was demonstrated by low occurrence of newly positive tuberculin skin tests (12%\u201316%) and conversions (8%\u201317%) among contacts. Targeted TB education, screening, and treatment for ESRD patients at highest risk for TB exposure (eg, non\u2013US-born persons), using interferon-gamma release assays and short course LTBI regimens (ie, isoniazid-rifapentine weekly for 12 weeks or rifampin daily for 4 months) may be an effective overall strategy for reducing TB burden in ESRD patients.<\/jats:p>","DOI":"10.1017\/ice.2018.219","type":"journal-article","created":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T00:49:59Z","timestamp":1537404599000},"page":"1367-1374","source":"Crossref","is-referenced-by-count":26,"title":["Epidemiology, detection, and management of tuberculosis among end-stage renal disease patients"],"prefix":"10.1017","volume":"39","author":[{"given":"Reiko C.","family":"Okada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pennan M.","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Skarbinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit S.","family":"Chitnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2018,9,20]]},"reference":[{"key":"S0899823X18002192_ref27","first-page":"1","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis","volume":"49","year":"2000","journal-title":"MMWR Recomm Rep"},{"key":"S0899823X18002192_ref8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029563"},{"key":"S0899823X18002192_ref15","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.09231209"},{"key":"S0899823X18002192_ref45","unstructured":"McGill University. Randomized clinical trial comparing 4RIF vs. 9INH for LTBI treatment-effectiveness. ClinicalTrials.gov website. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00931736. NLM Identifier: NCT00931736. Posted 2009; updated 2017. Accessed February 13, 2018."},{"key":"S0899823X18002192_ref5","doi-asserted-by":"publisher","DOI":"10.1159\/000045974"},{"key":"S0899823X18002192_ref23","first-page":"873","article-title":"Tuberculosis transmission in a renal dialysis center\u2014Nevada, 2003","volume":"53","year":"2004","journal-title":"Morb Mortal Wkly Rep"},{"key":"S0899823X18002192_ref4","doi-asserted-by":"publisher","DOI":"10.1086\/501679"},{"key":"S0899823X18002192_ref20","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2017.4916"},{"key":"S0899823X18002192_ref44","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-149-10-200811180-00003"},{"key":"S0899823X18002192_ref6","first-page":"341","article-title":"Tuberculosis in California dialysis patients","volume":"8","author":"Ahmed","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"S0899823X18002192_ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3062.2009.00475.x"},{"key":"S0899823X18002192_ref38","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/140.5.1189"},{"key":"S0899823X18002192_ref34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1104875"},{"key":"S0899823X18002192_ref25","first-page":"1","article-title":"Guidelines for the investigation of contacts of persons with infectious tuberculosis","volume":"54","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"S0899823X18002192_ref29","first-page":"1650","article-title":"Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat Mycobacterium tuberculosis infection","volume":"60","year":"2011","journal-title":"Morb Mortal Wkly Rep"},{"key":"S0899823X18002192_ref28","unstructured":"Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep 2005;54:1\u2013141."},{"key":"S0899823X18002192_ref16","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2012.07.019"},{"key":"S0899823X18002192_ref21","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.15.0081"},{"key":"S0899823X18002192_ref37","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001329"},{"key":"S0899823X18002192_ref35","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3182a94a2f"},{"key":"S0899823X18002192_ref22","doi-asserted-by":"publisher","DOI":"10.1067\/mic.2002.123394"},{"key":"S0899823X18002192_ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1974.03230450032020"},{"key":"S0899823X18002192_ref3","first-page":"989","article-title":"Risk of tuberculosis in dialysis patients: a population-based study","volume":"2","author":"Chia","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"key":"S0899823X18002192_ref17","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000000451"},{"key":"S0899823X18002192_ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2004.00545.x"},{"key":"S0899823X18002192_ref39","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/145.1.36"},{"key":"S0899823X18002192_ref9","doi-asserted-by":"publisher","DOI":"10.1159\/000360183"},{"key":"S0899823X18002192_ref42","doi-asserted-by":"publisher","DOI":"10.1378\/chest.130.6.1712"},{"key":"S0899823X18002192_ref7","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfl488"},{"key":"S0899823X18002192_ref32","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200512-1953OC"},{"key":"S0899823X18002192_ref11","unstructured":"Unites States Renal Data System. 2016 USRDS annual data report: epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Kidney Diseases. Bethesda, MD; 2016."},{"key":"S0899823X18002192_ref33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1005136"},{"key":"S0899823X18002192_ref31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3062.2005.00103.x"},{"key":"S0899823X18002192_ref36","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-017-1004-5"},{"key":"S0899823X18002192_ref41","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.17.1863"},{"key":"S0899823X18002192_ref40","doi-asserted-by":"publisher","DOI":"10.7326\/M17-0609"},{"key":"S0899823X18002192_ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-139X.2012.01093.x"},{"key":"S0899823X18002192_ref24","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01010208"},{"key":"S0899823X18002192_ref26","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00950208"},{"key":"S0899823X18002192_ref30","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199457110-00029"},{"key":"S0899823X18002192_ref43","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200404-478OC"},{"key":"S0899823X18002192_ref1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-139X.2003.03010.x"},{"key":"S0899823X18002192_ref18","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268817000334"},{"key":"S0899823X18002192_ref19","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2017.3941"},{"key":"S0899823X18002192_ref10","doi-asserted-by":"publisher","DOI":"10.1177\/0033354917698117"}],"container-title":["Infection Control &amp; Hospital Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0899823X18002192","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T02:29:51Z","timestamp":1580696991000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0899823X18002192\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,20]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0899823X18002192"],"URL":"https:\/\/doi.org\/10.1017\/ice.2018.219","relation":{},"ISSN":["0899-823X","1559-6834"],"issn-type":[{"value":"0899-823X","type":"print"},{"value":"1559-6834","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,20]]}}}